187 related articles for article (PubMed ID: 18358870)
1. [Genetics of motor neuron disorders].
Corcia P; Praline J; Vourc'h P; Andres C
Rev Neurol (Paris); 2008 Feb; 164(2):115-30. PubMed ID: 18358870
[TBL] [Abstract][Full Text] [Related]
2. TDP-43 in differential diagnosis of motor neuron disorders.
Dickson DW; Josephs KA; Amador-Ortiz C
Acta Neuropathol; 2007 Jul; 114(1):71-9. PubMed ID: 17569066
[TBL] [Abstract][Full Text] [Related]
3. [Experimental approach to the gene therapy of motor neuron disease with the use of genes hypoxia-inducible factors].
Ismailov ShM; Barykova IuA; Shmarov MM; Tarantul VZ; Barskov IV; Kucherianu VG; Brylev LV; Logunov DIu; Tutykhina IL; Bocharov EV; Zakharova MN; Naroditskiĭ BS; Illarioshkin SN
Genetika; 2014 May; 50(5):591-601. PubMed ID: 25715475
[TBL] [Abstract][Full Text] [Related]
4. Role of complement in motor neuron disease: animal models and therapeutic potential of complement inhibitors.
Woodruff TM; Costantini KJ; Taylor SM; Noakes PG
Adv Exp Med Biol; 2008; 632():143-58. PubMed ID: 19025120
[TBL] [Abstract][Full Text] [Related]
5. Activation of the stress-activated MAP kinase, p38, but not JNK in cortical motor neurons during early presymptomatic stages of amyotrophic lateral sclerosis in transgenic mice.
Holasek SS; Wengenack TM; Kandimalla KK; Montano C; Gregor DM; Curran GL; Poduslo JF
Brain Res; 2005 May; 1045(1-2):185-98. PubMed ID: 15910777
[TBL] [Abstract][Full Text] [Related]
6. [Superoxide dismutase-1 (SOD-1) gene mutation-dependent mechanisms of neural degeneration in amyotrophic lateral sclerosis].
Iłzecka J
Neurol Neurochir Pol; 2001; 35(3):461-9. PubMed ID: 11732268
[TBL] [Abstract][Full Text] [Related]
7. Basic and clinical research on amyotrophic lateral sclerosis and other motor neuron disorders in Italy: recent findings and achievements from a network of laboratories.
Beghi E; Mennini T;
Neurol Sci; 2004 Jun; 25 Suppl 2():S41-60. PubMed ID: 15197603
[TBL] [Abstract][Full Text] [Related]
8. Mutant mice, Cu,Zn superoxide dismutase, and motor neuron degeneration.
McCord JM
Science; 1994 Dec; 266(5190):1586-7. PubMed ID: 7985031
[No Abstract] [Full Text] [Related]
9. Amyotrophic lateral sclerosis. Insights from genetics.
Brown RH
Arch Neurol; 1997 Oct; 54(10):1246-50. PubMed ID: 9341570
[TBL] [Abstract][Full Text] [Related]
10. Primary lateral sclerosis as a phenotypic manifestation of familial ALS.
Brugman F; Wokke JH; Vianney de Jong JM; Franssen H; Faber CG; Van den Berg LH
Neurology; 2005 May; 64(10):1778-9. PubMed ID: 15911810
[TBL] [Abstract][Full Text] [Related]
11. Amyotrophic lateral sclerosis: all roads lead to Rome.
Gonzalez de Aguilar JL; Echaniz-Laguna A; Fergani A; René F; Meininger V; Loeffler JP; Dupuis L
J Neurochem; 2007 Jun; 101(5):1153-60. PubMed ID: 17250677
[TBL] [Abstract][Full Text] [Related]
12. Progressive spinal axonal degeneration and slowness in ALS2-deficient mice.
Yamanaka K; Miller TM; McAlonis-Downes M; Chun SJ; Cleveland DW
Ann Neurol; 2006 Jul; 60(1):95-104. PubMed ID: 16802286
[TBL] [Abstract][Full Text] [Related]
13. Imbalanced excitatory to inhibitory synaptic input precedes motor neuron degeneration in an animal model of amyotrophic lateral sclerosis.
Schütz B
Neurobiol Dis; 2005 Oct; 20(1):131-40. PubMed ID: 16137574
[TBL] [Abstract][Full Text] [Related]
14. Mutant SOD1 causes motor neuron disease independent of copper chaperone-mediated copper loading.
Subramaniam JR; Lyons WE; Liu J; Bartnikas TB; Rothstein J; Price DL; Cleveland DW; Gitlin JD; Wong PC
Nat Neurosci; 2002 Apr; 5(4):301-7. PubMed ID: 11889469
[TBL] [Abstract][Full Text] [Related]
15. Genetically engineered mouse models of neurodegenerative diseases.
Wong PC; Cai H; Borchelt DR; Price DL
Nat Neurosci; 2002 Jul; 5(7):633-9. PubMed ID: 12085093
[TBL] [Abstract][Full Text] [Related]
16. [Motor neuron disease].
Niwa J; Sobue G
Tanpakushitsu Kakusan Koso; 2004 May; 49(7 Suppl):1127-8. PubMed ID: 15168546
[No Abstract] [Full Text] [Related]
17. Phenotypic heterogeneity in motor neuron disease patients with CuZn-superoxide dismutase mutations in Scandinavia.
Andersen PM; Nilsson P; Keränen ML; Forsgren L; Hägglund J; Karlsborg M; Ronnevi LO; Gredal O; Marklund SL
Brain; 1997 Oct; 120 ( Pt 10)():1723-37. PubMed ID: 9365366
[TBL] [Abstract][Full Text] [Related]
18. TDP-43 pathology in familial frontotemporal dementia and motor neuron disease without Progranulin mutations.
Seelaar H; Schelhaas HJ; Azmani A; Küsters B; Rosso S; Majoor-Krakauer D; de Rijk MC; Rizzu P; ten Brummelhuis M; van Doorn PA; Kamphorst W; Willemsen R; van Swieten JC
Brain; 2007 May; 130(Pt 5):1375-85. PubMed ID: 17360763
[TBL] [Abstract][Full Text] [Related]
19. Mouse motor neuron disease caused by truncated SOD1 with or without C-terminal modification.
Watanabe Y; Yasui K; Nakano T; Doi K; Fukada Y; Kitayama M; Ishimoto M; Kurihara S; Kawashima M; Fukuda H; Adachi Y; Inoue T; Nakashima K
Brain Res Mol Brain Res; 2005 Apr; 135(1-2):12-20. PubMed ID: 15857664
[TBL] [Abstract][Full Text] [Related]
20. Association of a paraneoplastic motor neuron disease with anti-Ri antibodies and a novel SOD1 I18del mutation.
Diard-Detoeuf C; Dangoumau A; Limousin N; Biberon J; Vourc'h P; Andres CR; de Toffol B; Praline J
J Neurol Sci; 2014 Feb; 337(1-2):212-4. PubMed ID: 24296360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
